2 cialis 20 mg viagra generic nl opiniones cialis generico prednisone taper 60 mg doxycycline 50 mg australia generic options propecia 100mg zoloft withdrawal propranolol 20 mg dosage antibiotic cipro 500mg wellbutrin generic version generico cipro xr 1000 metformin pcos mg doxycycline 100mg gerd metformin 500 mg ratiopharm generic metformin names generic name cialis discount viagra 50mg nome generico propranolol cialis online store 1000 mg metformin pregnancy erythromycin 500mg alcohol cialis 10 mg beipackzettel cialis 24 mg uk cialis online propecia 5mg order viagra online original tetracycline 250 mg dosage buy lexapro cod cialis 20 mg wallgrens viagra online review xenical 120 mg cheap cialis generico prezzi metformin 1700 mg levitra india buy how viagra 800mg cialis generic 20 mg cialis 20mg bangkok cytotec 50 mg pfizer glucophage 500 mg tablets generic wellbutrin watson valtrex online pharmacy buy cialis bali lisinopril generic celebrex 25 mg buy synthroid order viagra 150 mg generic levitra legitimate viagra versus generic kamagra gold 100mg generic chewable viagra online viagra uk cialis 5mg ausreichend 1000 mg glucophage xr cialis 4o mg diflucan 180 mg 5mg prednisone dosage generic viagra ray cipro 750 mg bid generic viagra 16 buy viagra 800mg zoloft 50 mg opinioni cialis 5mg price cialis vendita online glucophage 500mg preis cheap viagra expensive viagra jet online vidal xenical 120 mg frozen zithromax 200mg cialis 20 mg 2 tablets celebrex 200 mg buy buy nolvadex ireland 800 mg black cialis cheapest cialis malaysia buy generic wellbutrin medicamento lexapro 15mg lexapro dosage 70 mg nolvadex generic tablets generic viagra vs prednisone generic drug lexapro generic alcohol buy zithromax antibiotic taking 20mg levitra liquid nolvadex mg prednisone 5mg propecia 1 mg 90 tablets lexapro generic alternatives cialis cheap Washington vanzare viagra online 2012 lexapro 15mg generico phenergan 25 mg insomnia xenical apotheke online viagra online apotheker cialis 20mg n2 buy nolvadex india cheap levitra sale 5 mg prednisone pregnancy viagra seal online wirkungsweise cialis 5mg celebrex celecoxib 200 mg prednisone 40 mg pregnant clomid 50mgs augmentin 500mg uses le nexium 20mg propranolol bula generico levitra 10 mg orosolubile 5mg lexapro pill propecia generic version propranolol 40mg ansiedade amoxil capsule 500mg order lasix cheap levitra 20 mg 8 doxycycline 100mg kopen online medications viagra zoloft 200 mg strattera 80 mg buy order nexium 40mg order viagra samples generic cytotec 200 mcg viagra online xlpharmacy prednisone 20 mg 10 days cialis 5mg oad viagra online quality buying viagra beijing lisinopril cinfa 20 mg doxycycline online mastercard lily cialis 20mg augmentin 50mg viagra 50 mg phuket prednisone 5mg bronchitis lexapro buy canada diflucan 150 mg forum blueberry 100 mg viagra pharmacy viagra generic nexium 40 mg generika augmentin 875 mg prices cialis 5 mg citalopram generic viagra klonopin online viagra prices cialis 20mg 121doc levitra 10 mg kullanimi nolvadex 25mg fake clomid australia online buy 5 clomid tablets erythromycin 500mg indications buy cialis johannesburg cialis generic 10mg germany viagra online bactrim 240 mg cialis 20mg pakistan generic cialis 2.5mg levitra online a viagra 100 mg 4 comprimidos cialis 10mg fta generic viagra manufacture buy clomid cheap florida metformin 850 mg online lexapro zoloft generic brands cipro 1a 250 mg legal clomid online cipro 200 mg generico zithromax 250 mg vidal overview diflucan 150 mg buy viagra kuala glucophage xr 500 mg mg propecia 50mg clomid daily buy 20mg cialis walmart levitra 20mg augmentin suspension 457 mg costo levitra 20 mg generic lexapro formula lexapro 30 mgs viagra onlineutah prescription viagra online generic viagra 600mg xenical en generico lisinopril 20 mg rx 534 nolvadex 10mg men doxycycline mono 50 mg viagra 25 mg effects levitra 10 mg duracion buying viagra spain viagra 100 mg 10 prednisone 60mg sidefects estonia generic cialis viagra 100mg phiser cheap australian viagra viagra generic uae augmentin 875 mg dose efeitos viagra 100mg buy legal nolvadex wellbutrin 75 mg cost zithromax 100mg sachet generic lisinopril mylan viagra generic company priligy order generic super viagra phenergan tablets 25 mg generic viagra brasil amoxil tablets 250mg cheap 50 mg viagra cialis 10 mg beter viagra 10 mg zithromax buy cheap zoloft borderline personality buspar generic form zovirax 250 mg flakon cytotec buy usa lisinopril 2mg online consultation propecia 36 hour cialis mg buy viagra wien doxycycline 100mg dogs propecia msd online lisinopril 10 5 mg buspar 600 mg overdose cap doxycycline 100mg buy doxycycline sydney vanzare cialis 2.5 mg aciclovir 200mg zovirax cialis soft 5mg nexium 40 mg pills lexapro price 20 mg global generic wellbutrin cialis dosage 60 mg viagra trusted online viagra generic soft prednisone 200 mg pcos clomid 50mg generico viagra portugal metformin 1000 mg daily brand viagra 100 mg zovirax online australia buy erythromycin uk buy 20 mg doxycycline cialis 20 mg break viagra canada cheap tadalafila cialis 5 mg lexapro reviews 10 mg buy women viagra buy viagra fast lasix 400mg generic dari xenical clomid generic canada viagra 100 mg preis nolvadex 60mg start tab clomid 100mg com generic glucophage zithromax 1 gram 1000 mg tetracycline 100 mg buy strattera pharmacy cheap viagra pharmacy green viagra 3800 mg periactin uk buy diflucan 50 mg capsulas celebrex 200 mg tabs lisinopril 20 mg tablets doxycycline monohydrate 150 mg 500 mg of tetracycline cialis tablets 10mg xenical 120 mg price buy generic zithromax cialis 20 mg canadian lisinopril 40 mg lupi zithromax 500 mg vidal zoloft 100 mg levitra 40mg generic wellbutrin generic cost cheap cialis marbella tadalafil generic cialis nolvadex tamoxifen 10 mg buy cialis store generic levitra soft harga levitra 20 mg buy kamagra canadian nexium buy online order generic clomid propecia 1 mg cut levitra cheap usa cialis 20mg schweiz 10 mg prednisone withdrawal nolvadex buy tamoxifen buy valtrex australia zovirax 200mg capsules nexium 20 mg canada phenergan 25 mg nausea cialis compresse 5 mg cialis dose 30 mg levitra 5mg alcohol 20mg cialis boner cialis 2.5 mg effectiveness generic propecia buy cialis 5mg tadalafil cialis 15 mg zithromax 600 mg egypt levitra 5 mg costo cialis 5 mg treatment buy zithromax iv 150mg sr wellbutrin prednisone 20 mg information cialis 100 mg fiyatlari kupim cialis generic 20mg cialis pills fake cialis online generic viagra manufactures xenical 120 mg contraindicaciones zoloft 50mg nexium 40 mg diarrhea synthroid 100 mg cost 300 mg of zoloft lisinopril dosage 5mg purchase bactrim generic zoloft 100mg bula viagra femminile online generic lisinopril hydrochlorothiazide clomid ile mg zithromax online usa viagra 20mg ervaring arret zoloft 25 mg viagra online legal augmentin zawiesina 457 mg propecia cheapest price uk cheap kamagra prednisone 5mg 3 days prednisone 10mg day 200 mg of diflucan metformin 500 mg kosten buy dapoxetine london 35 mg levitra dangerous doxycycline 100mg birds xenical 120 mg rezeptfrei levitra going generic celebrex 200 mg generic 200mg zoloft daily purchase Levitra 10 mg cheap levitra tab clomid 100mg au bactrim 800 buy prednisone 5mg cancer buy amoxil 50 mg lisinopril 10mg buy cipro antibiyotik 1000 mg effet 40 mg cialis buy kamagra liverpool cipro online order prednisone stopping 20mg viagra 150 mg cipla genuine 5mg cialis diflucan 150 mg n1 cheap lisinopril 20 mg cipro 500mg dosing sildenafil 100mg viagra free viagra 150 mg 20 mg cialis break zoloft sale online levitra 20 mg billiger cialis tablets cheapest zoloft 50 mg cost levitra 30mg etkisi nolvadex generic name prednisone 20mg pills levitra 20mg directions zithromax 250 mg preis nolvadex 20 mg pills diflucan tablets 100mg omeprazole 20 mg nexium lisinopril biogaran 20 mg zithromax 250 mg n1 buy zithromax capsules propecia finasteride generic aurochem generic cialis comprar viagra 25mg prednisone uses generic clomid online buy generic lexapro date kamagra 100 mg contrareembolso generic cialis 200 mg cialis 20mg bula buy cipra cialis round 200 mg bactrim clomid 150mg ovulation kamagra 100 online kaufen cheap 25mg viagra glucophage nombre generico online pharmacy tetracycline buy metformin 500 mg buy cialis bangkok thyroid synthroid generic wellbutrin generic manufacturers 7 mg prednisone viagra sale 25mg assunzione cialis 20 mg diflucan online shopping propecia cheapest kamagra 100mg discount buying generic cialis viagra online argentina glucophage 300 mg levitra 20mg fta 4 500 mg diflucan generic viagra shop levitra orodispersible generic generic problem viagra took 2 cialis 20 mg brown viagra 150mg buying viagra 4 pills cialis 50 mg tablets lisinopril 10 mg ulotka viagra 150 mg paypal viagra buy amoxil 125 mg 5 ml lisinopril 40 mg 4214 v propecia generic same cialis 2.5 mg holland levitra 10mg 4st viagra generic oscommerce xenical online sale buy metformin 850 mg order hydrochlorothiazide 25 mg buy xenical malaysia clomid 50mg dosage buy viagra cod 1750 mg of augmentin viagra femenina online order zithromax generic 36hr cialis cialis cheap 10 mg fake viagra 100mg 100 mg cipro online buy 10 mg cialis buy kamagra thailand periactin generic brand lisinopril 5 mg nebenwirkungen generic lexapro difference generico viagra preco valtrex order canada pastillas cytotec genericos levitra 20mg erfahrungen viagra generic 50 mg xenical buy singapore 5 mg cialis review viagra 50mg walgreens clomid nolvadex online cialis 200 mg price strattera borderline buy online viagra buy online nolvadex 604 cheapest levitra online diflucan generic fluconazole order viagra lexapro 5 mg day prednisone taper 20mg hyclate doxycycline 100mg buy propecia philippines priligy 30mg malaysia lexapro generic paronia 50 or 100mg viagra viagra pesni online buy bulk cialis prednisone 40mg sciatica nexium 40 mg kullanim prohormones clomid 50 mg indikasi lisinopril 10 mg lexapro 10 mg tablet 100 mg phenergan 75 mg phenergan valacyclovir valtrex generic xenical 250mg malaysia buy viagra belfast zoloft mg doses amoxil 100 mg cats doxycycline mg malaria generic augmentin dosing coupons generic cialis celebrex prospect 100mg online tablets viagra colombian viagra generic viagra onlines generic viagra 26 cialis zoloft generic reviews levitra half 20 mg 400mg. viagra cheap 5mg cialis diflucan online buy cheap propecia nexium dosierung 40 mg metformin 10000 mg valtrex generic discount 200 mgs. viagra online cheap viagra cialis 20 mg dosing doxycycline 500 mg tablet nexium generic sale viagra sells online zovirax 200mg dosing doxycycline mono 100mg prednisone 50mg price levitra 20mg vardenafil celebrex celecoxib 400 mg
Home Biz of Baseball - Interviews Interview - Jim Duquette - Orioles VP of Baseball Operations

Like Shoot to Thrill - An AC/DC Tribute on Facebook!

An authentic tribute of AC/DC that covers the best of the Bon Scott era and the best of Brian Johnson's material

Who's Online?

We have 911 guests online

Atom RSS

Interview - Jim Duquette - Orioles VP of Baseball Operations PDF Print E-mail
User Rating: / 3
PoorBest 
Written by Maury Brown   
Monday, 15 January 2007 06:31

Jim DuquetteJim Duquette, like the rest of the Baltimore Orioles organization, is working to stem the flow of losing seasons. Duquette, starting his second year with the organization, and Jim Flanagan, Executive Vice President, are coming off the ninth consecutive losing season in Baltimore, and the pressure from fans to right the ship is increasing.

There are signs that the Orioles may be on track to improving the team. The question is, will that improvement be enough when compared with the moves that the rest of the AL East has made?

While the Orioles were in the mix for a number of key free agents this off-season, they abandoned their approach of going hard after those free agents when the market set higher than in the recent past. When the off-season started, Duquette said the Orioles “went down two different, but parallel paths” in which they planned on trying to acquire key free agents, but had a backup plan in case the market saw elevated free spending. At that point, addressing the bullpen became a key focus, along with acquiring a solid middle-of-the-lineup bat.

Duquette, the cousin of former Red Sox GM Dan Duquette, started his MLB career as the Assistant Director, Minor League Operations for the Mets in 1995, and was promoted to Assistant Director, Minor Leagues and Scouting in 1996. He left in ’97 to work with the Astros as Director, Player Development, but was back in ’98 with the Mets. By 1999 he was the Assistant GM and, until 2003, held that position, along with a variety of other sub-titles (Minor Leagues and Scouting, Director of Player Development, Player Personnel). In 2004 he was made Senior Vice President, General Manager, and in ’05 held the title of Senior Vice President, Baseball Operations.

In October of last year, he left the Mets to join the Orioles, where he now holds the title of Vice President of Baseball Operations. Duquette assists Executive Vice President of Baseball Operations Mike Flanagan in the day-to-day handling of the department. Those key aspects include contract negotiations, as well as assisting in salary arbitration and player personnel decisions at the major league level.

The following interview covers a variety of topics, including the recent trade of Rodrigo Lopez to the Colorado Rockies in exchange for Jim Miller and Jason Burch, as well as how the free spending this off-season has impacted how the Orioles have gone after key player pieces they feel the need to add. Additional topics include how Baltimore is addressing the left field position and the bullpen, the possible Opening Day lineup, how you balance competing for key free agents against overspending for overvalued talent, where Jay Payton and Aubrey Huff will fit in the equation, and much more.

Maury Brown for Biz of Baseball: Let’s start with the activity on Friday. The Orioles traded RHP Rodrigo Lopez to the Colorado Rockies in exchange for RHP Jim Miller and RHP Jason Burch. On top of that, you signed RHP Todd Williams to a one-year contract. Along with the other additions this off-season, what do these moves do for the club coming into 2007?

Jim Duquette: Well, I think the main thing for us is that we felt we had depth in the starting rotation. We didn’t think that Rodrigo would really accept a roll in the bullpen, and so I think the main thing is it gives us some payroll flexibility and it also allows Rodrigo a fresh start somewhere else. So, I think the two combined were what we were looking to do.

In conjunction with Todd Williams, he’s a guy that came off a little bit of a rough year; a down year, last year, but two years ago he was our best reliever pitching in the 8th inning. He’s a motivated kid right now after being non-tendered and wants to come back and prove that last year was an aberration, so we're hopeful that he’ll have a year like he had a couple of years ago. And, we felt that risk wasn’t all that high, either.

BizBall: What’s your take on how this off-season has been in terms of some of the salaries being offered in comparison to some in the recent past? Do you see the contract offers as a market correction, or as overvaluations in many cases?

Jim Duquette quoteDuquette: I think it’s an overvaluation. Hopefully, it’s a blip. I’m hopeful that we get back to more reasonable levels next year. I think, historically speaking, you tend to see a rise in the free agent market in the years that the collective bargaining agreement has been signed or renewed.

I also think there’s been—over the past few years—I don’t know if it’s a collective effort, but more of a conscious effort to monitor payroll. I think you’re given the opportunity to sign a veteran player who’s making $2 or $3 million, or you have the opportunity to bring up a young player from your system, I think more teams are allowing the younger player the opportunity to play. So, I think teams in general have managed their payroll, in comparison to revenues, much better in the past few years, so you already have money around to spend. And then, the increased revenue sharing in the new collective bargaining agreement was a recipe for this type of market. I don’t think we could have predicted this type of market, but certainly I think everyone in baseball was predicting a spike.

BizBall: This off-season sees the Orioles with the 6th highest level of off-season spending, three spots higher than the Yankees (Editor's Note: at publication, the Orioles had spent $76,400,000, compared to $61,250,000 for the Yankees, and $170,850,000 for the Red Sox, who are at the 3rd highest off-season spending behind the Giants and Cubs). At the same time you were unable to land any of the key free agents, such as Alfonso Soriano, or Carlos Lee, who it was reported the Orioles were interested in. How do you compete for key players in an inflated market where you have to say, “The going price is now overvaluing the player”? How do you balance that?

Jim Duquette quoteDuquette: That’s a difficult balance, there’s no doubt about it. Our main desire was, if we could, to get a top-of-the-rotation starter and the middle-of-the-lineup bat. We knew we couldn’t afford both, so we were going to try and get one. And, we also needed to improve our bullpen. So, it really came down to making choices for us. Were we going to put all of our eggs in one basket of one or two players, and then try and fill other needs with crapshoots? We decided to quickly change course during the middle of the off-season and go down the road of spreading out the money and try and fill a number of needs. We obviously revamped our bullpen and felt the acquisitions of Payton and Huff, while they weren’t the impact type bats, they gave us quality and versatility in the lineup both in the field with Payton, and Huff with what he’s capable of doing. Seeing where the market was going, we started down one path, and quickly changed plans. We went down two different, but parallel paths, as we had looked at this contingency in August or September.

BizBall: Left field was obviously a serious concern going into the off-season. The Orioles have brought in Huff, Payton, and Jon Knott, all of which could be used as options at the position. As it stands now, how do the Orioles plan to use these players, and will they all be used in left field at some point?

Duquette: I think you’re going to see that [they will be slotted] in leftfield, and even at first base as we sort through some of these guys. Last year those were our least productive positions defensively. We feel like while we have some candidates there, there is some question about their defensive abilities, as well. That’s why a guy like Payton was so important for us, because even when he’s not playing, he’s a defensive player that can go out and play all three outfield position if we need to have a late inning outfield replacement. So, I don’t know how it’s all going to sort out. We’re going to give opportunities to guys like Knott, or even [Jason] Dubois, we’ll take a look at him. A guy like J.R. House who can catch and play first base. We have some other interesting guys to throw in the mix—Terry Tiffee is an interesting guy. I think all of these types of guys will be in competition for various different spots, but most likely they’ll be bench roles. I think that in Spring Training we’ll have to see how left field and first base sort out.

BizBall: With Payton now in the fold, are there plans to use him in center along with Corey Patterson when you are facing lefthanded starters?

Jay PaytonDuquette: Yeah, I think we have to look at that, just because Corey struggled against lefties, [although he] hopefully will be better against them this year. I think he hit .207 against lefthanders, and that’s where Payton hit .296 against lefties, and he was pretty consistent against both lefties and righties. So, I think that one of the areas, other than the bullpen, that we were terrible in [was hitting lefties]—I believe we were 16-36 or 33 versus lefthanded pitching. [Ed. note: The Orioles were 16-33 against lefthanded pitching in 2006.] So, our feeling was that even though Huff didn’t hit well against lefties last season, he's done so in the past and could help us, and Payton was obviously a guy that could help us. So, that’s our hope—that we’ll get a little better balance in our lineup this year.

BizBall: The bullpen was another weak spot last season for the Orioles. Last year, the bullpen was 19-25 with a 5.25 ERA and 35 saves in 56 opportunities. To address that situation, you’ve picked up four relievers this off-season in Danys Baez, Chad Bradford, Jamie Walker, and Scott Williamson, with Baez setting up for Chris Ray. Walk us through the strategy with the new bullpen, and what are you looking for from them in relationship to the starting rotation?

Duquette: Well, there’s two or three different thought processes when it came to bolstering the bullpen.

First off, I think, as an organization, we had a little bit of a credibility issue, coming off a ninth straight losing season. I think that there was a little bit of skepticism out there that there was a willingness by the organization to spend money. So, our feeling was, well, if we aren’t going to be able to afford these position players, let’s go out and try and get the best relievers on the market, even though we know as a group they’re generally inconsistent from year to year, we tried to select the top of the class—both from the left side and the right side. And, both statistically or evaluation wise, or a combination of both, we had our eyes set on Justin Speier, Baez, Bradford, Roberto Hernandez, and the other guy was [Joe] Borowski. We felt comfortable if we could get two of those guys that would really help us. And then from the left side, we really thought that Walker and [Scott] Schoeneweis were the two kind of elite guys, even though Schoeneweis didn’t do all that well in Toronto this year, but he pitched well in Cincinnati. So, those were the targets from the left side, and we felt if we could get one of those guys we’d be satisfied. That’s the way we decided to go to bolster the bullpen. We lost 18 games after being tied or leading after six innings last year. We’re not expecting to win all of those games, but it’s not unrealistic to think that we could have won at least half of those games with a decent bullpen last year.

Brian RobertsBizBall: The Orioles currently have three players on the arbitration-eligible list: Erik Bedard, lhp; Patterson, of; and Brian Roberts, 2b. There was talk of trading Roberts in the off-season to Atlanta, but the deal did not occur. Why did the Orioles decide not to trade Roberts and what is the status of a contract extension for him?

Duquette: In the situation we’re in you have to be open to improving a club any way you can. So, when we were throwing out a proposal to Brian Roberts, we at least had to think about [trading him] and give it some serious consideration. In the end we decided not to do it for a number of reasons. Primarily, he is one of the guys that we rely on as the face of the organization—he and [Miguel] Tejada, in particular, are very popular players—they’re quality players at their position. I believe Roberts is one of the top leadoff guys in the game.

So, from our standpoint, we had started multi-year contract negotiations at the end of the year. So, the discussions are on-going, but we’d rather not get into the details of how those negotiations are going, or anything of that nature. But he’s clearly a guy that we would like to keep, even if it was only to buy one free-agent year, we’d like to try and keep him and eliminate the arbitration process year after year.

BizBall: The way that the market has been inflated this year, and with arbitration in the mix, do you feel that more clubs are going to try and wrap up those arbitration-eligible players outside of the free agency process?

Duquette: Yeah, I do. I think that one of the main reasons that you see less and less quality in the free-agent market is clubs trying to tie up some of these arbitration-eligible players by offering them extensions that leave them some level of security that first multi-year contract that these young guys sign. So therefore, the free agent market is the one that suffers the most. I think you're going to continue to see teams do that. Although, having said that, the timing, right now, after this year’s market, isn’t real good to find some value. I think you're still going to see teams sign their young players to multi-year extensions like the Mets did this year with [Jose] Reyes and [David] Wright.

BizBall: How close is the following lineup to what we might see on Opening Day, with Payton in the mix depending on left-handed starters?:

2B Brian Roberts
3B Melvin Mora
RF Nick Markakis
SS Miguel Tejada
LF Aubrey Huff
C Ramon Hernandez
DH Jay Gibbons
1B Kevin Millar
CF Corey Patterson

Duquette: Yeah, that’s a fair one there. I think that line up is one that you’ll see a fair amount of this year. I like the way, with Huff in there, how the line up spreads out one to nine. You have Jay Gibbons batting 7th in that particular lineup; if he’s swinging the bat the way he’s capable of swinging it, and with Ramon coming off the year he had last year, I really like that lineup. Pitchers are going to have a hard time getting through that lineup; there’s not many outs in that lineup.

BizBall: With the changes the Orioles have made in the off-season, the question becomes whether those moves will lead to enough improvement from last season when taking into account the moves that your AL East counterparts have made. What’s your assessment of what the Red Sox, Yankees and Devil Rays have done this off-season?

Jim Duquette quoteDuquette: Well, I think each team, it seems like everyone has improved. Everyone has gone out and spent money that they think makes them better. While we keep an eye on that, we can’t get caught up in it that much. We have to be more concerned about ourselves. Once we start winning ballgames, then we can worry about who we’re chasing, and everything else. Our goal was to not necessarily try to keep up with the Red Sox or keep up with the Yankees—we’re never going to have a payroll close to theirs, but from our standpoint let’s improve what we have. Let’s improve our bullpen. Get ourselves better defensively. Find ourselves a credible bat in the lineup. And then, let’s see how it all plays out on the field. We’re really looking forward to Spring Training to see how this all shakes out.

BizBall: Lastly, the Orioles have had nine consecutive losing seasons. I’m sure that you are working to keep from having it be a “decade of losing seasons.” I’m sure that there is the desire to win every season, but is there any sense of urgency in fielding a winning team this year more than in years prior?

Duquette: I don’t get caught up in that—maybe that’s because I’m only in my second year here, and I haven’t been here for that entire period of time. I do think that there is some level of, obviously, frustration with the fan base. I think they’ve shown that until we start winning, they're not going to show up to ballgames. Every year there’s a pressure that you put on yourself to win and get better, so I don’t particularly think that this year there’s more pressure, or less pressure. I think that there is a pressure that you put on yourself when you’re running a ballclub. Some of the players that we acquired, we didn’t bring them over here, and they didn’t come here to lose. I think there was kind of a losing-type atmosphere here for a period of time. I believe since I came on board there have been 16 new players, counting guys that have come up through the system, but 16 new faces projected to be on the 25 man roster. That’s a lot of change, and a lot of turnover, and obviously, we think that it’s for the better.


  • Interview conducted by Maury Brown on 1/13/07.
  • Special thanks to Dan Budreika for assisting.

To read other interviews on The Biz of Baseball with the likes of Jayson Stark, Ken Rosenthal, Stan Kasten, Marvin Miller, Bowie Kuhn, Bob Costas, and others, select the Interviews navigation element to the left on any page.

 
 
Banner

Poll

Should MLB Force Jeffery Loria to Sell the Marlins?